Pfizer

Uncategorized

GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines

/

Pharmaceutical giants GSK and Pfizer have reached a settlement to resolve a long-running patent dispute related to respiratory syncytial virus (RSV) vaccines. The legal battle, which revolved around patent infringement claims, has now been brought to a close through an agreement between the two companies. The lawsuit centered on allegations that Pfizer’s RSV vaccine infringed […]

battle, dispute, drug, infringement, medicine, patent, pharma, technology, Uncategorized

Madras High Court ruled in favor of Pfizer’s patent rights

/

In a recent global patent disputes, the Madras High Court has pronounced a ruling concerning the ongoing patent dispute in the United States involving Pfizer’s drug, VYNDAMAX (also known as TAFAMIDIS), which is used to treat a rare heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM). The case is in focus due to the high stakes

Scroll to Top